Year 2011,
Volume: 3 Issue: 1, 14 - 17, 01.04.2011
Abstract
References
- Kristensen SD. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoesis. Dan Med Bull 1992; 39:633–638.
- Endler G, Klimesch A, Schillinger M at al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399–404.
- Deedwania PC, Amsterdam EA, Vagelos RH. Evidence-based, cost-effective risk stratification and management after myocardial infarction. Arch Intern Med 1997;157:273–280.
- Morrow D, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acut coronary syndromes: a TIMI 11A sub study. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460–65.
- de Lemos JA, Antman EM, Giugliano RP, et al, for the TIMI 14 Investigators. ST segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol 2000;85:299–304.
- O’Rourke RA. Overview of trends in heart disease. Changing prognosis after myocardial infarction. Ann Epidemiol 1993;3:541–546.
- Bhatia L, Clesham GJ, Turner DR. Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction JRSM 2004;97:566–570.
- Schnöder R, Zeymer U, Wegscheider K, et al. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 in after start of streptokinase in acute myocardial infarction European Heart Journal 1999;20:1563–1571.
- Maggioni AP, Franzosi MG, Santoro E, et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Soprawivenza nell'lnfarto Miocardico II (GISSI–2), and The International Study Group. N Engl J Med 1992;327:1–6.
- ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group: A prospective trial of intrevenous Streptokinase in avute myocardial infarction N Engl J Med 1986;314:1465–1471.
- TEAM 2 Study Group. Does thrombolysis in myocardial infarction perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? J Am Coll Cardiol 1992;19:1–10
Year 2011,
Volume: 3 Issue: 1, 14 - 17, 01.04.2011
Abstract
Akut myokard infarktüsünden sonra bazı faktörler prognozu etkiler ve uzun dönemdeki yaşam süresini belirlemeye yardımcı olmak için kullanılabilirler. Bu nedenle myokard infarktüsünden sonra risk sınıflandırması oldukça önemlidir. ST segment yükselmeli myokard infarktüsünde, fibrinolitik tedavi sonrası koroner reperfüzyon invaziv ve noninvaziv olarak değerlendirilebilir. Noninvaziv reperfüzyon kriterlerinden ST segment rezolusyonu myokardiyal mikrosirkulatuar dolaşımı daha iyi yansıttığı için; klinik pratikte basit, ucuz ve kolay uygulanabilen bir parametre olarak prognoz tayininde kullanılabilir. Biz bu çalışmamızda ST segment rezolusyon derecesinin prognostik önemini araştırdık
References
- Kristensen SD. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoesis. Dan Med Bull 1992; 39:633–638.
- Endler G, Klimesch A, Schillinger M at al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399–404.
- Deedwania PC, Amsterdam EA, Vagelos RH. Evidence-based, cost-effective risk stratification and management after myocardial infarction. Arch Intern Med 1997;157:273–280.
- Morrow D, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acut coronary syndromes: a TIMI 11A sub study. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460–65.
- de Lemos JA, Antman EM, Giugliano RP, et al, for the TIMI 14 Investigators. ST segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol 2000;85:299–304.
- O’Rourke RA. Overview of trends in heart disease. Changing prognosis after myocardial infarction. Ann Epidemiol 1993;3:541–546.
- Bhatia L, Clesham GJ, Turner DR. Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction JRSM 2004;97:566–570.
- Schnöder R, Zeymer U, Wegscheider K, et al. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 in after start of streptokinase in acute myocardial infarction European Heart Journal 1999;20:1563–1571.
- Maggioni AP, Franzosi MG, Santoro E, et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Soprawivenza nell'lnfarto Miocardico II (GISSI–2), and The International Study Group. N Engl J Med 1992;327:1–6.
- ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group: A prospective trial of intrevenous Streptokinase in avute myocardial infarction N Engl J Med 1986;314:1465–1471.
- TEAM 2 Study Group. Does thrombolysis in myocardial infarction perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? J Am Coll Cardiol 1992;19:1–10
There are 11 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Articles |
| Authors | |
| Publication Date | April 1, 2011 |
| Published in Issue | Year 2011 Volume: 3 Issue: 1 |